BRIEF-Lexicon announces EMA acceptance of MAA for Sotagliflozin to treat adults with Type 1 Diabetes
March 29, 2018 at 02:20 AM EDT
* LEXICON PHARMACEUTICALS ANNOUNCES EMA ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION (MAA) FOR SOTAGLIFLOZIN TO TREAT ADULTS WITH TYPE 1 DIABETES Source text for Eikon: Further company coverage:
